Maintain BNY at current weight with mandated active overlay through Q3 earnings
Hold with mandated active overlay differentiates from four prior Holds that bled - Underweight re-enters a capped trade, Sell overreaches given structural floor at $134.50-$135.94 with 200 SMA rising, 14% ROE, $50T+ AUC franchise, G-SIB status, and 6.5% capital return yield, and Overweight/Buy is empirically invalidated by the 0-for-3 aggressive-buy trap documented across 09-17, 09-18, 09-24, and 09-25 reflections. Hold with the mandated active overlay and pre-committed Q3 decision tree is the only rating that captures the directional view, respects the binding empirical constraint from 09-28, and preserves optionality through the Q3 binary catalyst.
| Position | Action |
|---|---|
| If currently overweight | Trim 25-30% to neutral now (not the half-overlay 10-15%) |
| If at core weight | Layer 3-month protective put at $138-140 strike with full notional equivalent |
The technical "sell" signal is a deeply oversold trap that creates a high-probability, asymmetric entry point in a fundamentally accelerating business compounding book value at 15%+ annually with 6.5% total shareholder yield.
| Indicator | Value | Signal |
|---|---|---|
| RSI | 22.35 | bearish |
| MACD Line | -3.75 | bearish |
| MACD Signal Line | -2.57 | bearish |
| MACD Histogram | -1.18 | bearish |
| 10 EMA | 148.92 | bearish |
| 50 SMA | 157.69 | bearish |
| 200 SMA | 135.94 | neutral |
| Bollinger Middle (20 SMA) | 154.51 | neutral |
| Bollinger Upper | 168.03 | neutral |
| Bollinger Lower | 141.00 | neutral |
| ATR | 3.03 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $138-135.94 capitulation on >6M shares with bullish reversal candle and RSI divergence
Then: Defined add with hard stop below prior swing low
↩ rebuts: “Bear's 'stretched valuation' thesis at 17.3x P/E and 'near 52-week highs'”
· concedes: Q2 2026 balance sheet surge (23% QoQ asset jump, 56% cash increase) is unusual but explained by quarter-end positioning — timing shift, not earnings deterioration; Rate cuts would compress NII — agreed, but Polymarket shows 96% no cuts in 2026; 2027 risk is distant; AUM/market drawdown risk is real — a 10–20% drawdown would compress fees, though the 6.5% capital return yield provides cushion; Basel III endgame capital headwinds are real — BNY is a G-SIB and has been preparing; this is a 'Pace-of-Buyback' issue, not a 'Direction-of-Earnings' issue
BNY is a falling knife trading in a confirmed downtrend with a thin 5.5% cushion above the 200 SMA, decelerating fundamentals, weakening buyback support, and zero institutional or retail sponsorship—the risk/reward does not favor buying here.
· concedes: BNY has a real structural duopoly moat in custody banking; The 200 SMA has not yet been tested—untested support could hold; The 'no cuts in 2026' consensus is the base case and could play out as expected; Buybacks at 2-3.5% of daily volume are still a meaningful daily bid on quiet days
→ vs conservative: EPS deceleration from plus 9.4% to plus 4.1% is not a fundamental break—it is still positive growth; balance sheet positioning contradicts thesis of coming disappointment
→ vs conservative: Three-layer declining MA resistance does not confirm downtrend; 200 SMA at 135.94 is the boss and price is still 5.5% above it, indicating intact uptrend
→ vs conservative: Buyback reduction makes math BETTER for shareholders—more accretion per dollar retired at $143 vs. $165
→ vs conservative: Identified asymmetry correctly but wrong conclusion: patience is performance-killing when asymmetry favors you
→ vs neutral: Waiting for technical confirmation means entering 3.4% higher at 10 EMA ($148.92), 7.4% higher at 20 SMA ($154.51), and missing the move entirely at 50 SMA ($157.69)
→ vs neutral: Confirmation trading on extreme oversold in high-quality compounders turns 20% annual returns into 9% annual returns
| neutral |
| VWMA (~20-day) | 150.87 | bearish |
| Close (2026-10-01) | 143.92 | neutral |
Support: 141 · 135.94 · 130 · 140 | Resistance: 148.92 · 154.51 · 157.69 · 162 · 164.84
The technical posture argues for caution on initiating new longs without a reversal trigger, but the RSI setup increases the probability of a near-term bounce or consolidation toward the 148–154 zone. The 200 SMA at ~$135.94 is the critical level to watch — a hold preserves the secular trend; a break would signal a larger structural deterioration. ATR of 3.03 indicates moderate, non-panic volatility; volume of 6.29M shares on 2026-10-01 confirmed distribution on the latest decline.
Market Cap
$98.65B
Trailing P/E
17.25x
Forward P/E
14.17x
PEG Ratio
1.09
Price/Book
2.47x
EPS (Diluted, TTM)
$8.43
Forward EPS
$10.26
Dividend Yield
1.54%
Beta
1.05
52-Week High
$165.84
52-Week Low
$103.11
50-Day Moving Average
$157.72
200-Day Moving Average
$136.63
Book Value/Share
$58.82
Revenue (TTM)
$21.4B
Total Revenue 2022
$16,186M
Total Revenue 2023
$17,344M
Total Revenue 2024
$18,258M
Total Revenue 2025
$19,759M
Net Interest Income 2022
$3,504M
Net Interest Income 2023
$4,345M
Net Interest Income 2024
$4,312M
Net Interest Income 2025
$4,944M
Net Income 2022
$2,556M
Net Income 2023
$3,302M
Net Income 2024
$4,530M
Net Income 2025
$5,549M
Net Income (TTM)
$6,024M
Diluted EPS 2022
$2.90
Diluted EPS 2023
$4.00
Diluted EPS 2024
$5.80
Diluted EPS 2025
$7.40
Diluted EPS Q1 2025
$1.93
Diluted EPS Q2 2025
$1.88
Diluted EPS Q3 2025
$2.02
Diluted EPS Q4 2025
$2.24
Diluted EPS Q1 2026
$2.45
Diluted EPS Q2 2026
~$2.55
Profit Margin
29.4%
Operating Margin
40.0%
Return on Equity (ROE)
14.1%
Return on Assets (ROA)
1.26%
Revenue CAGR
6.9%
Diluted Share Count 2022
815M
Diluted Share Count 2025
717M
Total Assets 2022
$405.8B
Total Assets 2025
$455.3B
Total Assets Q2 2026
$561.5B
Cash & Equivalents Q2 2026
$187.0B
Net Loans Q2 2026
$101.0B
Long-Term Debt Q2 2026
$32.8B
Total Equity Q2 2026
$44.8B
Tangible Book Value 2022
$14.6B
Tangible Book Value Q2 2026
$22.5B
Goodwill
$16.7B
Operating Cash Flow 2025
$6,730M
Free Cash Flow 2025
$5,177M
Capex 2025
$1,553M
Common Dividends 2025
$1,447M
Stock Buybacks 2025
$4,535M
Total Shareholder Yield
~6.5%
Q1 2026 Buyback
$983M
Q4 2025 Buyback
$1,045M
Q3 2025 Buyback
$1,849M
Strengths
Concerns
BNY is a world-leading custody bank and asset manager with $98.65B market cap servicing $50T+ in assets under custody. The company has delivered exceptional fundamental performance—revenue grew from $16.2B to $21.4B (6.9% CAGR), net income doubled from $2.6B to $6B, and EPS surged from $2.90 to $8.43 TTM—driven by rising rate environment expanding net interest income and disciplined expense control. BNY is a premier capital return story with $4.5B+ annual buybacks and 1.54% dividend yield, generating ~6.5% total shareholder yield, though valuation appears stretched near 52-week highs and the stock faces headwinds if the Fed cuts rates aggressively.
Macro: Fed hold (96% no-cut 2026) with soft September jobs miss driving equity rally and Treasury yield easing; Iran war narrative lifting inflation expectations but consensus pricing remains benign (8% P[inflation >5% 2026]); recession risk at 8% US / 8% UK / 5% Japan; equity markets rallying on jobs miss and fading rate-hike fears.